Press release (12 November 2014):
A Shared Global Agenda to Fight Alzheimer’s Disease: Addressing the Barriers to Innovation
This workshop provided an international forum for stakeholders to articulate achievements and opportunities in biomedical research and health innovation for Alzheimer’s disease and other dementia. It discussed the challenges and barriers to the development of disease-modifying treatments and diagnostics for Alzheimer’s disease and other dementia. This included the need to invigorate biomarker R&D, adopt more innovative clinical trials, and encourage an adaptive regulatory process. Stakeholders engaged in discussions to consider options towards more innovative research and governance models.
Through an exchange on good practices, representatives from governments, regulatory agencies, academia, industry, and patient organisations heard about progress in:
This was a follow-up event to the OECD workshop on “Better Health through Biomedicine: Innovative Governance” in Berlin, Germany in 2010. It is intended to provide input to ongoing international policy discussions on Alzheimer’s and dementia, including the work of the World Dementia Council.
Participation was by invitation. For further information, please contact: Hermann.Garden@oecd.org
Final agenda (pdf)